Handelsbanken Fonder Ab Insmed Inc Transaction History

Handelsbanken Fonder Ab

$24.3 Billion
Q1 2025

A detailed history of Handelsbanken Fonder Ab transactions in Insmed Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 49,181 shares of INSM stock, worth $5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

49,181

Previous 45,281 8.61%

Holding current value

$5 Million

Previous $3.13 Million 20.03%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$65.25 - $83.83 $254,475 - $326,937	3,900 Added 8.61%	49,181 $3.75 Million
Q4 2024 Feb 03, 2025	BUY	$66.29 - $76.63 $112,693 - $130,270	1,700 Added 3.9%	45,281 $3.13 Million
Q3 2024 Oct 04, 2024	BUY	$62.0 - $79.01 $545,600 - $695,288	8,800 Added 25.3%	43,581 $3.18 Million
Q2 2024 Aug 05, 2024	BUY	$22.0 - $69.71 $94,600 - $299,753	4,300 Added 14.11%	34,781 $2.33 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $48,868 - $56,886	1,900 Added 6.65%	30,481 $827,000
Q4 2023 Feb 01, 2024	BUY	$23.42 - $31.74 $16,394 - $22,218	700 Added 2.51%	28,581 $886,000
Q2 2023 Aug 02, 2023	SELL	$16.44 - $21.1 $24,660 - $31,650	-1,500 Reduced 5.11%	27,881 $588,000
Q1 2023 Apr 28, 2023	BUY	$16.26 - $21.73 $182,112 - $243,376	11,200 Added 61.6%	29,381 $501,000
Q4 2022 Feb 07, 2023	BUY	$16.98 - $23.15 $57,732 - $78,710	3,400 Added 23.0%	18,181 $363,000
Q3 2022 Oct 27, 2022	SELL	$20.88 - $28.21 $83,520 - $112,840	-4,000 Reduced 21.3%	14,781 $318,000
Q1 2022 May 11, 2022	SELL	$20.42 - $28.13 $104,142 - $143,463	-5,100 Reduced 21.36%	18,781 $441,000
Q2 2021 Aug 03, 2021	BUY	$24.17 - $36.01 $108,765 - $162,045	4,500 Added 23.22%	23,881 $680,000
Q3 2020 Nov 13, 2020	BUY	$26.0 - $34.5 $187,200 - $248,400	7,200 Added 59.11%	19,381 $623,000
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $171,873 - $358,365	12,181 New	12,181 $335,000

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Insmed Inc Transaction History